Cystatin C as a marker of cognitive function in elders: findings from the health ABC study

Ann Neurol. 2008 Jun;63(6):798-802. doi: 10.1002/ana.21383.

Abstract

We determined whether serum cystatin C, a novel measure of kidney function that colocalizes with brain beta-amyloid, is associated with cognition among 3,030 elders. Those with high cystatin C (n = 445; 15%) had worse baseline scores on Modified Mini-Mental State Examination or Digit Symbol Substitution Test (p <or= 0.02) compared with those with intermediate/low level and 7 years greater decline (p <or= 0.04). Incident cognitive impairment (decline >or=1.0 standard deviation) was greatest among those with high cystatin C (Modified Mini-Mental State Examination: 38 vs 25%; adjusted odds ratio, 1.92; 95% confidence interval, 1.37-2.69; Digit Symbol Substitution: 38 vs 26%; odds ratio, 1.54; 95% confidence interval, 1.10-2.15).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Aged
  • Aging / metabolism*
  • Alzheimer Disease / blood*
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / epidemiology
  • Biomarkers / analysis
  • Biomarkers / blood
  • Body Mass Index
  • Brain / metabolism*
  • Brain / physiopathology
  • Cognition Disorders / blood*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / epidemiology
  • Comorbidity
  • Cystatin C
  • Cystatins / analysis
  • Cystatins / blood*
  • Disease Progression
  • Educational Status
  • Female
  • Health Surveys
  • Humans
  • Kidney Diseases / blood*
  • Kidney Diseases / diagnosis
  • Kidney Diseases / epidemiology
  • Logistic Models
  • Male
  • Memory Disorders / blood
  • Memory Disorders / diagnosis
  • Memory Disorders / etiology
  • Prospective Studies
  • Racial Groups
  • Risk Factors
  • Sex Distribution
  • Smoking / epidemiology

Substances

  • Biomarkers
  • CST3 protein, human
  • Cystatin C
  • Cystatins